Key result
Identifying young patients with childhood hypertrophic cardiomyopathy at greatest risk of sudden cardiac death remains a major clinical challenge.
Highlights the clinical challenge of identifying young patients with childhood hypertrophic cardiomyopathy who are at greatest risk of sudden cardiac death.
Hypertrophic cardiomyopathy (HCM) is defined as left ventricular hypertrophy in the absence of loading conditions sufficient to cause the observed abnormality. The true prevalence in childhood is unknown; the aetiology is more heterogeneous than that seen in adult populations, and includes inborn errors of metabolism, malformation syndromes and neuromuscular syndromes. However, one of the greatest clinical challenges in managing young patients with HCM is identifying those at greatest risk of sudden cardiac death.
No takes yet. Share an insight, caveat, or question.
Norrish et al. (2018) conducted an editorial in Childhood Hypertrophic Cardiomyopathy. Identifying young patients with childhood hypertrophic cardiomyopathy at greatest risk of sudden cardiac death remains a major clinical challenge.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: